These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 21501447)
1. An evaluation of emerging vaccines for childhood meningococcal disease. Choudhuri D; Huda T; Theodoratou E; Nair H; Zgaga L; Falconer R; Luksic I; Johnson HL; Zhang JS; El Arifeen S; Nelson CB; Borrow R; Campbell H; Rudan I BMC Public Health; 2011 Apr; 11 Suppl 3(Suppl 3):S29. PubMed ID: 21501447 [TBL] [Abstract][Full Text] [Related]
2. An evaluation of emerging vaccines for childhood pneumococcal pneumonia. Webster J; Theodoratou E; Nair H; Seong AC; Zgaga L; Huda T; Johnson HL; Madhi S; Rubens C; Zhang JS; El Arifeen S; Krause R; Jacobs TA; Brooks AW; Campbell H; Rudan I BMC Public Health; 2011 Apr; 11 Suppl 3(Suppl 3):S26. PubMed ID: 21501444 [TBL] [Abstract][Full Text] [Related]
3. An evaluation of the emerging interventions against Respiratory Syncytial Virus (RSV)-associated acute lower respiratory infections in children. Nair H; Verma VR; Theodoratou E; Zgaga L; Huda T; Simões EA; Wright PF; Rudan I; Campbell H BMC Public Health; 2011 Apr; 11 Suppl 3(Suppl 3):S30. PubMed ID: 21501449 [TBL] [Abstract][Full Text] [Related]
4. Impact of serogroup A meningococcal conjugate vaccine for Africa. Stuart JM Hum Vaccin Immunother; 2018 May; 14(5):1116-1117. PubMed ID: 29194010 [TBL] [Abstract][Full Text] [Related]
5. An evaluation of respiratory administration of measles vaccine for prevention of acute lower respiratory infections in children. Higginson D; Theodoratou E; Nair H; Huda T; Zgaga L; Jadhav SS; Omer SB; Rudan I; Campbell H BMC Public Health; 2011 Apr; 11 Suppl 3(Suppl 3):S31. PubMed ID: 21501450 [TBL] [Abstract][Full Text] [Related]
6. Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data. Novak RT; Kambou JL; Diomandé FV; Tarbangdo TF; Ouédraogo-Traoré R; Sangaré L; Lingani C; Martin SW; Hatcher C; Mayer LW; Laforce FM; Avokey F; Djingarey MH; Messonnier NE; Tiendrébéogo SR; Clark TA Lancet Infect Dis; 2012 Oct; 12(10):757-64. PubMed ID: 22818241 [TBL] [Abstract][Full Text] [Related]
7. Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps. LaForce FM; Djingarey M; Viviani S; Preziosi MP Hum Vaccin Immunother; 2018 May; 14(5):1098-1102. PubMed ID: 28968148 [TBL] [Abstract][Full Text] [Related]
8. An evaluation of the emerging vaccines and immunotherapy against staphylococcal pneumonia in children. Huda T; Nair H; Theodoratou E; Zgaga L; Fattom A; El Arifeen S; Rubens C; Campbell H; Rudan I BMC Public Health; 2011 Apr; 11 Suppl 3(Suppl 3):S27. PubMed ID: 21501445 [TBL] [Abstract][Full Text] [Related]
9. Emergence of serogroup X meningococcal disease in Africa: need for a vaccine. Xie O; Pollard AJ; Mueller JE; Norheim G Vaccine; 2013 Jun; 31(27):2852-61. PubMed ID: 23623866 [TBL] [Abstract][Full Text] [Related]
10. Eliminating Meningococcal Epidemics From the African Meningitis Belt: The Case for Advanced Prevention and Control Using Next-Generation Meningococcal Conjugate Vaccines. Alderson MR; LaForce FM; Sobanjo-Ter Meulen A; Hwang A; Preziosi MP; Klugman KP J Infect Dis; 2019 Oct; 220(220 Suppl 4):S274-S278. PubMed ID: 31671447 [TBL] [Abstract][Full Text] [Related]
11. An evaluation of the emerging vaccines against influenza in children. Nair H; Lau E; Brooks W; Seong A; Theodoratou E; Zgaga L; Huda T; Jadhav SS; Rudan I; Campbell H BMC Public Health; 2013; 13 Suppl 3(Suppl 3):S14. PubMed ID: 24564565 [TBL] [Abstract][Full Text] [Related]
12. Vaccine prevention of meningococcal disease in Africa: Major advances, remaining challenges. Mustapha MM; Harrison LH Hum Vaccin Immunother; 2018 May; 14(5):1107-1115. PubMed ID: 29211624 [TBL] [Abstract][Full Text] [Related]
13. Meningococcal meningitis: vaccination outbreak response and epidemiological changes in the African meningitis belt. Carod Artal FJ Int Health; 2015 Jul; 7(4):226-7. PubMed ID: 25878213 [TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of expanding childhood routine immunization against Neisseria meningitidis serogroups C, W and Y with a quadrivalent conjugate vaccine in the African meningitis belt. Kuznik A; Iliyasu G; Lamorde M; Mahmud M; Musa BM; Nashabaru I; Obaro S; Mohammed I; Habib AG PLoS One; 2017; 12(11):e0188595. PubMed ID: 29190699 [TBL] [Abstract][Full Text] [Related]
15. Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa. Woods CW; Armstrong G; Sackey SO; Tetteh C; Bugri S; Perkins BA; Rosenstein NE Lancet; 2000 Jan; 355(9197):30-3. PubMed ID: 10615888 [TBL] [Abstract][Full Text] [Related]
16. From Epidemic Meningitis Vaccines for Africa to the Meningitis Vaccine Project. Aguado MT; Jodar L; Granoff D; Rabinovich R; Ceccarini C; Perkin GW Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S391-5. PubMed ID: 26553665 [TBL] [Abstract][Full Text] [Related]
17. Identifying optimal vaccination strategies for serogroup A Neisseria meningitidis conjugate vaccine in the African meningitis belt. Tartof S; Cohn A; Tarbangdo F; Djingarey MH; Messonnier N; Clark TA; Kambou JL; Novak R; Diomandé FV; Medah I; Jackson ML PLoS One; 2013; 8(5):e63605. PubMed ID: 23671685 [TBL] [Abstract][Full Text] [Related]
18. Technical Development of a New Meningococcal Conjugate Vaccine. Frasch CE; Kapre SV; Lee CH; Préaud JM Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S404-9. PubMed ID: 26553667 [TBL] [Abstract][Full Text] [Related]